##SAMPLE=<ID=NA12878_03,Gender=female,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=affected>
#chr	start	end	ref	obs	genotype	filter	quality	gene	variant_type	coding_and_splicing	RepeatMasker	dbSNP	1000g	ExAC	ExAC_sub	gnomAD	phyloP	MetaLR	Sift	PP2_HVAR	PP2_HDIV	OMIM	ClinVar	HGMD	COSMIC	GPD_gene	GPD_var	ihdb_hom	ihdb_het	ihdb_wt	ihdb_allsys_hom	ihdb_allsys_het	classification	classification_comment	validated	comment
chr1	62713224	62713224	C	G	hom		QUAL=1166;DP=37;AF=1.00;MQM=60	KANK4	missense	KANK4:NM_181712.4:missense:MODERATE:exon9/10:c.2803G>C:p.Val935Leu		rs2941679	0.9862	0.974	0.974	0.9598	0.6980	T	T,T,T,T	B,B	B,B					12227		0.9307	0.0594	0.0099	946	87				
chr1	62713246	62713246	G	A	het		QUAL=1649;DP=117;AF=0.44;MQM=60	KANK4	synonymous	KANK4:NM_181712.4:synonymous:LOW:exon9/10:c.2781C>T:p.His927His		rs10889315	0.3189	0.389	0.389	0.4209									COSM426544	12227		0.2772	0.4158	0.3069	189	491				
chr1	62728784	62728784	A	G	hom		QUAL=38124;DP=1194;AF=1.00;MQM=60	KANK4	missense	KANK4:NM_181712.4:missense:MODERATE:exon7/10:c.2519T>C:p.Val840Ala		rs2666472	0.7159	0.74	0.74	0.7338	2.8390	T	T,T,T	B,B	B,B				COSM4144131	12227		0.505	0.4257	0.0693	545	403				
chr1	62728838	62728838	T	C	hom		QUAL=35243;DP=1128;AF=1.00;MQM=60	KANK4	missense	KANK4:NM_181712.4:missense:MODERATE:exon7/10:c.2465A>G:p.His822Arg		rs2258470	0.7163	0.741	0.741	0.734	3.3070	T	T,T,T	B,B	B,B					12227		0.505	0.4257	0.0693	545	404				
chr1	62728861	62728861	T	C	hom		QUAL=35547;DP=1118;AF=1.00;MQM=60	KANK4	synonymous	KANK4:NM_181712.4:synonymous:LOW:exon7/10:c.2442A>G:p.Lys814Lys		rs2260581	0.7163	0.741	0.741	0.7338										12227		0.505	0.4257	0.0693	545	405				
chr1	62728918	62728918	G	A	hom		QUAL=5510;DP=180;AF=1.00;MQM=60	KANK4	synonymous	KANK4:NM_181712.4:synonymous:LOW:exon7/10:c.2385C>T:p.Pro795Pro		rs2262110	0.7161	0.742	0.742	0.7338										12227		0.505	0.4257	0.0693	547	404				
chr1	62732421	62732421	T	C	het		QUAL=13777;DP=857;AF=0.52;MQM=60	KANK4	missense	KANK4:NM_181712.4:missense:MODERATE:exon6/10:c.2302A>G:p.Thr768Ala		rs11207949	0.3055	0.284	0.284	0.2449	2.3800	T	T,T,T	B,B	B,B					12227		0.0297	0.4257	0.5446	50	368				
chr1	62738904	62738904	T	C	hom		QUAL=1818;DP=62;AF=1.00;MQM=60	KANK4	synonymous	KANK4:NM_181712.4:synonymous:LOW:exon3/10:c.1872A>G:p.Pro624Pro		rs7516290	0.8005	0.738	0.738	0.6733										12227		0.4554	0.4455	0.099	489	433				
chr1	62739198	62739198	G	A	het		QUAL=2166;DP=140;AF=0.49;MQM=60	KANK4	synonymous	KANK4:NM_181712.4:synonymous:LOW:exon3/10:c.1578C>T:p.Ser526Ser		rs17855078	0.2506	0.308	0.308	0.3309										12227		0.099	0.4653	0.4356	114	480				
chr1	62740065	62740065	A	G	het		QUAL=1790;DP=119;AF=0.49;MQM=60	KANK4	synonymous	KANK4:NM_181712.4:synonymous:LOW:exon3/10:c.711T>C:p.Gly237Gly		rs12127930	0.4822	0.452	0.452	0.4271									COSM4144132	12227		0.1881	0.495	0.3168	210	523				
chr1	62740446	62740446	T	C	hom		QUAL=7265;DP=230;AF=1.00;MQM=60	KANK4	synonymous	KANK4:NM_181712.4:synonymous:LOW:exon3/10:c.330A>G:p.Pro110Pro		rs2666506	0.8045	0.745	0.745	0.6742										12227		0.4455	0.4554	0.099	491	432				
chr1	62740449	62740449	T	C	hom		QUAL=7265;DP=230;AF=1.00;MQM=60	KANK4	synonymous	KANK4:NM_181712.4:synonymous:LOW:exon3/10:c.327A>G:p.Ser109Ser		rs2666507	0.781	0.737	0.737	0.6734										12227		0.4455	0.4554	0.099	489	433				
chr1	120458004	120458004	A	T	het		QUAL=2123;DP=127;AF=0.55;MQM=60	NOTCH2	synonymous	NOTCH2:NM_024408.3:synonymous:LOW:exon34/34:c.7341T>A:p.Gly2447Gly		rs6685892	0.1925	0.129	0.129	0.1038						600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];				18147		0	0.1188	0.8812	11	217				
chr1	120611964	120611964	G	C	het		QUAL=22127;DP=1927;AF=0.38;MQM=58	NOTCH2	missense	NOTCH2:NM_024408.3:missense:MODERATE:exon1/34:c.57C>G:p.Cys19Trp,NOTCH2:NM_001200001.1:missense:MODERATE:exon1/22:c.57C>G:p.Cys19Trp		rs11810554	0	0.406	0.406	0	0.7660	T,T	.,T	.,B,B	.,B,B	600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];			COSM132738	18147		0	0.9307	0.0693	5	1181				
chr1	120612006	120612006	G	A	het		QUAL=24336;DP=2004;AF=0.39;MQM=58	NOTCH2	synonymous	NOTCH2:NM_024408.3:synonymous:LOW:exon1/34:c.15C>T:p.Arg5Arg,NOTCH2:NM_001200001.1:synonymous:LOW:exon1/22:c.15C>T:p.Arg5Arg		rs4021006	0.394	0.422	0.422	0	1.0740					600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];	RCV000173523.1 [uncertain significance]; 		COSM1320072	18147		0	0.9307	0.0693	1	1178				
chr2	17942775	17942775	T	A	hom		QUAL=3027;DP=91;AF=1.00;MQM=60	GEN1	missense	GEN1:NM_001130009.1:missense:MODERATE:exon3/14:c.274T>A:p.Ser92Thr,GEN1:NM_182625.3:missense:MODERATE:exon3/14:c.274T>A:p.Ser92Thr		rs1812152	0.8137	0.714	0.714	0.6259	0.5670	T	T,T,T,T	B	B					9140		0.396	0.4653	0.1386	403	499				
chr2	17954027	17954027	G	A	hom		QUAL=959;DP=29;AF=1.00;MQM=60	GEN1	missense	GEN1:NM_001130009.1:missense:MODERATE:exon8/14:c.929G>A:p.Ser310Asn,GEN1:NM_182625.3:missense:MODERATE:exon8/14:c.929G>A:p.Ser310Asn		rs300175	0.977	0.993	0.993	0.9998	-2.1950	T	T,T,T	B	B					9140		1	0	0	1035	1				
chr2	17962450	17962450	A	G	hom		QUAL=3047;DP=93;AF=1.00;MQM=60	GEN1	synonymous	GEN1:NM_001130009.1:synonymous:LOW:exon14/14:c.1971A>G:p.Glu657Glu,GEN1:NM_182625.3:synonymous:LOW:exon14/14:c.1971A>G:p.Glu657Glu		rs300168	0.5739	0.576	0.576	0.5184										9140		0.2574	0.495	0.2475	276	540				
chr2	17962518	17962518	C	T	hom		QUAL=3588;DP=111;AF=1.00;MQM=60	GEN1	missense	GEN1:NM_001130009.1:missense:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile,GEN1:NM_182625.3:missense:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile		rs300169	0.758	0.698	0.698	0.6245	0.1800	T	T,T,T	B	B					9140		0.396	0.4653	0.1386	404	494				
chr2	215595164	215595164	G	A	het	pred_pathogenic_2	QUAL=334;DP=27;AF=0.44;MQM=60	BARD1	missense,non_coding_exon	BARD1:NM_000465.3:missense:MODERATE:exon10/11:c.1972C>T:p.Arg658Cys,BARD1:NM_001282543.1:missense:MODERATE:exon9/10:c.1915C>T:p.Arg639Cys,BARD1:NM_001282545.1:missense:MODERATE:exon6/7:c.619C>T:p.Arg207Cys,BARD1:NM_001282548.1:missense:MODERATE:exon5/6:c.562C>T:p.Arg188Cys,BARD1:NM_001282549.1:missense:MODERATE:exon4/5:c.433C>T:p.Arg145Cys,BARD1:NR_104212.1:non_coding_exon:MODIFIER:exon9/10:n.1965C>T:,BARD1:NR_104215.1:non_coding_exon:MODIFIER:exon8/9:n.1908C>T:,BARD1:NR_104216.1:non_coding_exon:MODIFIER:exon9/10:n.1164C>T:		rs3738888	0.0054	0.0079	0.0079,0.0123	0.0078	5.1650	T	D,D,D,D	P,D	B,B	601593 [BARD1 (confirmed) Breast cancer,susceptibility to];	RCV000130975.3 [benign]; 	CM067650 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=BARD1]; 	COSM3782110, COSM3782109	1919		0	0	1	0	12			n/a (1xTP, 0xFP)	
chr2	215632255	215632255	C	T	het		QUAL=3342;DP=109;AF=0.55;MQM=60	BARD1	missense,intron,non_coding_exon	BARD1:NM_000465.3:missense:MODERATE:exon6/11:c.1519G>A:p.Val507Met,BARD1:NM_001282543.1:missense:MODERATE:exon5/10:c.1462G>A:p.Val488Met,BARD1:NM_001282545.1:intron:MODIFIER:exon2/6:c.216-14976G>A:,BARD1:NM_001282548.1:intron:MODIFIER:exon1/5:c.159-14976G>A:,BARD1:NM_001282549.1:intron:MODIFIER:exon3/4:c.364+24766G>A:,BARD1:NR_104212.1:non_coding_exon:MODIFIER:exon5/10:n.1512G>A:,BARD1:NR_104215.1:non_coding_exon:MODIFIER:exon4/9:n.1455G>A:,BARD1:NR_104216.1:non_coding_exon:MODIFIER:exon5/10:n.711G>A:		rs2070094	0.3662	0.378	0.378	0.2758	-5.2640	T	T,T	B,B	B,B	601593 [BARD1 (confirmed) Breast cancer,susceptibility to];	RCV000128872.2 [benign]; 	CM034384 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=BARD1]; 	COSM3757929, COSM3757930	1919		0.1881	0.396	0.4158	192	669				
chr2	215632256	215632256	A	G	hom		QUAL=3342;DP=109;AF=0.55;MQM=60	BARD1	synonymous,intron,non_coding_exon	BARD1:NM_000465.3:synonymous:LOW:exon6/11:c.1518T>C:p.His506His,BARD1:NM_001282543.1:synonymous:LOW:exon5/10:c.1461T>C:p.His487His,BARD1:NM_001282545.1:intron:MODIFIER:exon2/6:c.216-14977T>C:,BARD1:NM_001282548.1:intron:MODIFIER:exon1/5:c.159-14977T>C:,BARD1:NM_001282549.1:intron:MODIFIER:exon3/4:c.364+24765T>C:,BARD1:NR_104212.1:non_coding_exon:MODIFIER:exon5/10:n.1511T>C:,BARD1:NR_104215.1:non_coding_exon:MODIFIER:exon4/9:n.1454T>C:,BARD1:NR_104216.1:non_coding_exon:MODIFIER:exon5/10:n.710T>C:		rs2070093	0.7706	0.813	0.813	0.7806						601593 [BARD1 (confirmed) Breast cancer,susceptibility to];	RCV000162380.1 [benign]; 			1919		0.6733	0.2673	0.0594	949	445				
chr2	215645464	215645464	C	G	het		QUAL=1317;DP=79;AF=0.53;MQM=60	BARD1	missense,intron,non_coding_exon	BARD1:NM_000465.3:missense:MODERATE:exon4/11:c.1134G>C:p.Arg378Ser,BARD1:NM_001282543.1:missense:MODERATE:exon3/10:c.1077G>C:p.Arg359Ser,BARD1:NM_001282545.1:intron:MODIFIER:exon2/6:c.215+16321G>C:,BARD1:NM_001282548.1:intron:MODIFIER:exon1/5:c.159-28185G>C:,BARD1:NM_001282549.1:intron:MODIFIER:exon3/4:c.364+11557G>C:,BARD1:NR_104216.1:intron:MODIFIER:exon3/9:n.507-11428G>C:,BARD1:NR_104212.1:non_coding_exon:MODIFIER:exon3/10:n.1127G>C:,BARD1:NR_104215.1:non_coding_exon:MODIFIER:exon2/9:n.1070G>C:		rs2229571	0.4593	0.548	0.548	0.6008	-0.6010	T	T,T	B,B	B,B	601593 [BARD1 (confirmed) Breast cancer,susceptibility to];	RCV000132162.2 [benign]; 	CM076014 [CLASS=DP MUT=ALT PHEN="Breast cancer reduced risk association with" GENE=BARD1]; 	COSM3757932, COSM3757931	1919		0.3762	0.4851	0.1386	496	715				
chr2	215674224	215674224	G	A	het	pred_pathogenic_1	QUAL=10769;DP=775;AF=0.49;MQM=60	BARD1,LOC101928103	missense,upstream_gene,non_coding_exon	BARD1:NM_000465.3:missense:MODERATE:exon1/11:c.70C>T:p.Pro24Ser,BARD1:NM_001282543.1:missense:MODERATE:exon1/10:c.70C>T:p.Pro24Ser,BARD1:NM_001282545.1:missense:MODERATE:exon1/7:c.70C>T:p.Pro24Ser,BARD1:NM_001282548.1:missense:MODERATE:exon1/6:c.70C>T:p.Pro24Ser,BARD1:NM_001282549.1:missense:MODERATE:exon1/5:c.70C>T:p.Pro24Ser,LOC101928103:NR_110292.1:upstream_gene:MODIFIER::n.-1G>A:,BARD1:NR_104212.1:non_coding_exon:MODIFIER:exon1/10:n.212C>T:,BARD1:NR_104215.1:non_coding_exon:MODIFIER:exon1/9:n.212C>T:,BARD1:NR_104216.1:non_coding_exon:MODIFIER:exon1/10:n.212C>T:		rs1048108	0.3313	0.367	0.367	0.3474	0.9680	T	T,D	B	B	601593 [BARD1 (confirmed) Breast cancer,susceptibility to];	RCV000162363.1 [benign]; 	CM076015 [CLASS=DP MUT=ALT PHEN="Breast cancer reduced risk association with" GENE=BARD1]; 	COSM442275, COSM1482743			0.198	0.3465	0.4554	191	693				
chr2	220416942	220416942	G	C	hom		QUAL=1037;DP=33;AF=1.00;MQM=60	OBSL1,MIR3132,TMEM198	splice_region&intron,upstream_gene,downstream_gene	OBSL1:NM_015311.2:splice_region&intron:LOW:exon18/20:c.5309-4C>G:,MIR3132:NR_036082.1:upstream_gene:MODIFIER::n.-1C>G:,TMEM198:NM_001005209.1:downstream_gene:MODIFIER::c.*1477G>C:,OBSL1:NM_001173431.1:downstream_gene:MODIFIER::c.*4946C>G:		rs34490902	0.3876	0.409	0.409	0.4551						610991 [OBSL1 (confirmed) 3-M syndrome 2];	RCV000175465.1 [benign]; 					0.1584	0.5149	0.3267	230	622				
chr2	220417266	220417266	C	T	hom	pred_pathogenic_3	QUAL=4444;DP=146;AF=1.00;MQM=60	OBSL1,MIR3132,TMEM198	missense,upstream_gene,downstream_gene	OBSL1:NM_015311.2:missense:MODERATE:exon18/21:c.5300G>A:p.Arg1767Gln,MIR3132:NR_036082.1:upstream_gene:MODIFIER::n.-1G>A:,TMEM198:NM_001005209.1:downstream_gene:MODIFIER::c.*1477C>T:,OBSL1:NM_001173431.1:downstream_gene:MODIFIER::c.*4946G>A:		rs59332477	0.3766	0.416	0.416	0.4456	3.5850	T	D,T	D	D	610991 [OBSL1 (confirmed) 3-M syndrome 2];			COSM3757971			0.1485	0.495	0.3564	226	620				
chr2	220419236	220419236	T	C	hom		QUAL=14166;DP=460;AF=1.00;MQM=60	OBSL1,TMEM198	synonymous,downstream_gene	OBSL1:NM_015311.2:synonymous:LOW:exon15/21:c.4836A>G:p.Thr1612Thr,TMEM198:NM_001005209.1:downstream_gene:MODIFIER::c.*1477T>C:,OBSL1:NM_001173431.1:downstream_gene:MODIFIER::c.*4946A>G:		rs10932813	0.9852	0.996	0.996	0.9996						610991 [OBSL1 (confirmed) 3-M syndrome 2];						1	0	0	1297	2				
chr2	220419339	220419339	T	C	hom		QUAL=21464;DP=685;AF=1.00;MQM=60	OBSL1,TMEM198	missense,downstream_gene	OBSL1:NM_015311.2:missense:MODERATE:exon15/21:c.4733A>G:p.Gln1578Arg,TMEM198:NM_001005209.1:downstream_gene:MODIFIER::c.*1477T>C:,OBSL1:NM_001173431.1:downstream_gene:MODIFIER::c.*4946A>G:		rs10932814	0.9611	0.985	0.985	0.9925	0.1950	T	T,T	B	B	610991 [OBSL1 (confirmed) 3-M syndrome 2];						1	0	0	1290	9				
chr2	220420956	220420956	A	G	hom	pred_pathogenic_1	QUAL=1332;DP=50;AF=1.00;MQM=60	OBSL1	synonymous	OBSL1:NM_015311.2:synonymous:LOW:exon14/21:c.4395T>C:p.Asp1465Asp,OBSL1:NM_001173431.1:synonymous:LOW:exon14/14:c.4395T>C:p.Asp1465Asp		rs10932816	0.9637	0.989	0.989	0.9996	-3.7700	T	D,.			610991 [OBSL1 (confirmed) 3-M syndrome 2];			COSM4133493	18539		1	0	0	1305	3				
chr2	220421417	220421417	C	G	hom		QUAL=23326;DP=726;AF=1.00;MQM=60	OBSL1	missense	OBSL1:NM_015311.2:missense:MODERATE:exon13/21:c.4095G>C:p.Glu1365Asp,OBSL1:NM_001173431.1:missense:MODERATE:exon13/14:c.4095G>C:p.Glu1365Asp		rs1983210	0.7246	0.74	0.74	0.7336	0.9020	T,T	T,T,T,T,.	P,P,B,.	B,P,B,.	610991 [OBSL1 (confirmed) 3-M syndrome 2];			COSM442368	18539		0.6337	0.3465	0.0198	758	478				
chr2	220422774	220422774	A	G	hom		QUAL=23920;DP=748;AF=1.00;MQM=60	OBSL1	synonymous,downstream_gene	OBSL1:NM_015311.2:synonymous:LOW:exon11/21:c.3561T>C:p.Pro1187Pro,OBSL1:NM_001173431.1:synonymous:LOW:exon11/14:c.3561T>C:p.Pro1187Pro,OBSL1:NM_001173408.1:downstream_gene:MODIFIER::c.*3392T>C:		rs2278201	0.4191	0.429	0.429	0.4331	-4.6180	T				610991 [OBSL1 (confirmed) 3-M syndrome 2];			COSM3757974	18539		0.1386	0.4851	0.3762	210	630				
chr2	220430203	220430203	C	T	hom		QUAL=23625;DP=730;AF=1.00;MQM=60	OBSL1	missense	OBSL1:NM_015311.2:missense:MODERATE:exon6/21:c.2168G>A:p.Arg723Lys,OBSL1:NM_001173431.1:missense:MODERATE:exon6/14:c.2168G>A:p.Arg723Lys,OBSL1:NM_001173408.1:missense:MODERATE:exon6/9:c.2168G>A:p.Arg723Lys		rs1039898	0.7927	0.865	0.865	0.9043	-0.1200	T	T,T,T,T,T	B,B,B,B	B,B,B,B	610991 [OBSL1 (confirmed) 3-M syndrome 2];			COSM4133496, COSM4133495	18539		0.8515	0.1386	0.0099	1043	236				
chr2	220435034	220435034	A	G	hom		QUAL=20225;DP=634;AF=1.00;MQM=60	OBSL1,INHA	synonymous,upstream_gene	OBSL1:NM_015311.2:synonymous:LOW:exon1/21:c.921T>C:p.Leu307Leu,OBSL1:NM_001173431.1:synonymous:LOW:exon1/14:c.921T>C:p.Leu307Leu,OBSL1:NM_001173408.1:synonymous:LOW:exon1/9:c.921T>C:p.Leu307Leu,INHA:NM_002191.3:upstream_gene:MODIFIER::c.-144A>G:		rs10180675	0.7833	0.861	0.861	0.9044						610991 [OBSL1 (confirmed) 3-M syndrome 2];	RCV000173448.1 [benign]; 		COSM4133504, COSM4133503			0.8713	0.1287	0	1045	233				
chr3	10085536	10085536	A	G	het		QUAL=3006;DP=292;AF=0.43;MQM=60	FANCD2	synonymous	FANCD2:NM_033084.3:synonymous:LOW:exon14/43:c.1122A>G:p.Val374Val,FANCD2:NM_001018115.1:synonymous:LOW:exon14/44:c.1122A>G:p.Val374Val		rs34046352	0	0.122	0.122	0						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];			COSM3759562, COSM3759563	8009		0	0.2574	0.7426	0	474				
chr3	10106532	10106532	C	T	het		QUAL=1466;DP=74;AF=0.64;MQM=60	FANCD2	missense	FANCD2:NM_033084.3:missense:MODERATE:exon23/43:c.2141C>T:p.Pro714Leu,FANCD2:NM_001018115.1:missense:MODERATE:exon23/44:c.2141C>T:p.Pro714Leu		rs3864017	0	0.155	0.155	0	-0.1810	T	T,T,T,T	B,B	B,B	613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];	RCV000120989.1 [not provided]; 			8009		0.0099	0.2376	0.7525	32	430				
chr3	10138069	10138069	T	G	het		QUAL=11320;DP=767;AF=0.47;MQM=60	FANCD2,FANCD2OS	synonymous,intron	FANCD2:NM_033084.3:synonymous:LOW:exon42/43:c.4098T>G:p.Leu1366Leu,FANCD2:NM_001018115.1:synonymous:LOW:exon42/44:c.4098T>G:p.Leu1366Leu,FANCD2OS:NM_173472.1:intron:MODIFIER:exon2/2:c.*43+7813A>C:		rs2272125	0.2422	0.187	0.187	0.1647						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];		CM066071 [CLASS=DP MUT=ALT PHEN="Breast cancer increased risk association with" GENE=FANCD2]; 	COSM3759565, COSM3759566			0.0099	0.2475	0.7426	42	444				
chr3	142168331	142168331	C	T	hom		QUAL=1580;DP=48;AF=1.00;MQM=60	ATR,XRN1	synonymous,upstream_gene	ATR:NM_001184.3:synonymous:LOW:exon47/47:c.7875G>A:p.Gln2625Gln,XRN1:NM_019001.4:upstream_gene:MODIFIER::c.-119G>A:,XRN1:NM_001282857.1:upstream_gene:MODIFIER::c.-119G>A:,XRN1:NM_001282859.1:upstream_gene:MODIFIER::c.-119G>A:		rs1802904	0.9163	0.865	0.865	0.8614						601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];	RCV000079601.6 [other]; 					0.7228	0.2673	0.0099	1189	373				
chr3	142178144	142178144	C	T	het		QUAL=1272;DP=77;AF=0.55;MQM=60	ATR	missense	ATR:NM_001184.3:missense:MODERATE:exon43/47:c.7274G>A:p.Arg2425Gln		rs2229032	0.1022	0.132	0.132	0.1578	0.0440	T	T,T	B	B	601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];	RCV000123787.1 [benign]; RCV000145330.1 [benign]; 		COSM149485	1774		0.0396	0.2178	0.7426	37	414				
chr3	142188337	142188337	A	C	het	pred_pathogenic_1	QUAL=11942;DP=680;AF=0.56;MQM=60	ATR	missense	ATR:NM_001184.3:missense:MODERATE:exon38/47:c.6394T>G:p.Tyr2132Asp		rs28910273	0.002	0.0033	0.0033	0.0069	2.3460	T	T,D	B	B	601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];	RCV000145327.1 [uncertain significance]; 			1774		0	0	1	0	17				
chr3	142217537	142217537	A	G	het		QUAL=4602;DP=347;AF=0.51;MQM=60	ATR	synonymous	ATR:NM_001184.3:synonymous:LOW:exon32/47:c.5460T>C:p.Tyr1820Tyr		rs2227932	0.0669	0.093	0.093	0.1062						601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];	RCV000123788.1 [benign]; RCV000145320.1 [likely benign]; 			1774		0.0099	0.1188	0.8713	19	255				
chr3	142277575	142277575	A	T	het		QUAL=3913;DP=267;AF=0.46;MQM=60	ATR	synonymous	ATR:NM_001184.3:synonymous:LOW:exon8/47:c.1776T>A:p.Gly592Gly		rs2227930	0.598	0.553	0.553	0.595						601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];	RCV000145291.5 [other]; 		COSM149486	1774		0.396	0.4257	0.1782	550	763				
chr3	142281612	142281612	A	G	het		QUAL=8098;DP=524;AF=0.48;MQM=60	ATR	missense	ATR:NM_001184.3:missense:MODERATE:exon4/47:c.632T>C:p.Met211Thr		rs2227928	0.5974	0.552	0.552	0.5955	1.2730	T	T,T	B	B	601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];	RCV000079600.6 [other]; 		COSM149487	1774		0.396	0.4257	0.1782	550	762				
chr5	80149981	80149981	A	G	hom		QUAL=27953;DP=894;AF=1.00;MQM=60	MSH3	missense	MSH3:NM_002439.4:missense:MODERATE:exon21/24:c.2846A>G:p.Gln949Arg		rs184967	0.9022	0.873	0.873	0.8355	0.4010	T	T,T	B	B	600887 [MSH3 (provisional) Endometrial carcinoma,somatic];		CM076322 [CLASS=DP MUT=REF PHEN="Proximal colon cancer increased risk association with" GENE=MSH3]; 	COSM4160036	16907		0.7327	0.2178	0.0495	987	403				
chr5	80168937	80168937	G	A	hom		QUAL=3734;DP=111;AF=1.00;MQM=60	MSH3	missense&splice_region	MSH3:NM_002439.4:missense&splice_region:MODERATE:exon23/24:c.3133G>A:p.Ala1045Thr		rs26279	0.7202	0.73	0.73	0.7094	1.0140	T	T,T	B	B	600887 [MSH3 (provisional) Endometrial carcinoma,somatic];		CM076321 [CLASS=DP MUT=REF PHEN="Colorectal cancer increased risk association with" GENE=MSH3]; 		16907		0.5248	0.3663	0.1089	697	591				
chr7	6036980	6036980	G	C	hom		QUAL=714;DP=22;AF=1.00;MQM=60	PMS2	synonymous,non_coding_exon	PMS2:NM_000535.5:synonymous:LOW:exon7/15:c.780C>G:p.Ser260Ser,PMS2:NR_003085.2:non_coding_exon:MODIFIER:exon7/15:n.862C>G:		rs1805319	0.8313	0.809	0.809	0.8148						600259 [PMS2 (confirmed) Mismatch repair cancer syndrome|Colorectal cancer,hereditary nonpolyposis,type 4];	RCV000162392.1,RCV000030372.3 [benign,benign]; RCV000079112.4 [benign]; RCV000131484.2 [benign]; 		COSM4162330	20856		0.6931	0.2574	0.0495	1111	467				
chr7	128846328	128846328	G	C	hom		QUAL=28334;DP=899;AF=1.00;MQM=60	SMO	synonymous	SMO:NM_005631.4:synonymous:LOW:exon6/12:c.1164G>C:p.Gly388Gly		rs2228617	0.7562	0.797	0.797	0.8391						601500 [SMO (provisional) Basal cell carcinoma,somatic];			COSM4004294	27463		0.7822	0.2079	0.0099	819	228				
chr7	142460313	142460313	T	C	hom		QUAL=4873;DP=163;AF=0.99;MQM=60	PRSS1	synonymous	PRSS1:NM_002769.4:synonymous:LOW:exon4/5:c.486T>C:p.Asp162Asp		rs6666	0.3966	0.369	0.369	0						276000 [PRSS1 (confirmed) Pancreatitis,hereditary|Trypsinogen deficiency];		CM086253 [CLASS=DP MUT=REF PHEN="Pancreatitis chronic association with" GENE=PRSS1]; 	COSM4161889	21576		0.2574	0.5842	0.1584	157	933				
chr7	142460865	142460865	T	C	hom		QUAL=10084;DP=347;AF=1.00;MQM=59	PRSS1	synonymous	PRSS1:NM_002769.4:synonymous:LOW:exon5/5:c.738T>C:p.Asn246Asn		rs6667	0.3938	0.504	0.504	0						276000 [PRSS1 (confirmed) Pancreatitis,hereditary|Trypsinogen deficiency];				21576		0.3465	0.495	0.1584	443	685				
chr9	17342383	17342383	C	T	hom		QUAL=984;DP=30;AF=1.00;MQM=60	CNTLN	synonymous	CNTLN:NM_017738.3:synonymous:LOW:exon12/26:c.1827C>T:p.Asp609Asp		rs1442527	0.9495	0.986	0.986	0.9994										4625		1	0	0	1032	2				
chr9	17394536	17394536	C	T	hom		QUAL=1755;DP=55;AF=1.00;MQM=60	CNTLN	missense	CNTLN:NM_017738.3:missense:MODERATE:exon15/26:c.2084C>T:p.Thr695Ile		rs7035276	0.7806	0.822	0.822	0.8763	0.3250	T	T,T,T	B,B,B	B,B,B					4625		0.7228	0.2574	0.0198	770	229				
chr9	17394996	17394996	T	C	hom		QUAL=3134;DP=97;AF=1.00;MQM=60	CNTLN	synonymous	CNTLN:NM_017738.3:synonymous:LOW:exon15/26:c.2544T>C:p.His848His		rs3739489	0.8411	0.879	0.879	0.9149										4625		0.8317	0.1584	0.0099	873	157				
chr9	17409366	17409366	G	A	hom		QUAL=12093;DP=378;AF=1.00;MQM=60	CNTLN	synonymous	CNTLN:NM_017738.3:synonymous:LOW:exon16/26:c.2691G>A:p.Thr897Thr		rs2780211	0.8389	0.875	0.875	0.9115									COSM3982792	4625		0.8218	0.1683	0.0099	864	165				
chr9	35074917	35074917	T	C	hom		QUAL=3116;DP=98;AF=1.00;MQM=60	FANCG,VCP	splice_region&intron,upstream_gene	FANCG:NM_004629.1:splice_region&intron:LOW:exon12/13:c.1636+7A>G:,VCP:NM_007126.3:upstream_gene:MODIFIER::c.-390A>G:		rs587118	0.2202	0.396	0.396	0.4993						602956 [FANCG (confirmed) Fanconi anemia,complementation group G];						0.2871	0.4752	0.2376	375	791				
chr9	98209594	98209594	G	A	het	pred_pathogenic_1	QUAL=1349;DP=67;AF=0.69;MQM=60	PTCH1	missense	PTCH1:NM_000264.3:missense:MODERATE:exon23/24:c.3944C>T:p.Pro1315Leu,PTCH1:NM_001083607.1:missense:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu,PTCH1:NM_001083606.1:missense:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu,PTCH1:NM_001083604.1:missense:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu,PTCH1:NM_001083605.1:missense:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu,PTCH1:NM_001083602.1:missense:MODERATE:exon23/24:c.3746C>T:p.Pro1249Leu,PTCH1:NM_001083603.1:missense:MODERATE:exon23/24:c.3941C>T:p.Pro1314Leu		rs357564	0.3968	0.38	0.38	0.3298	9.4050	T	D,D,D,D,D,D,D,D	P,P,P	P,P,B	601309 [PTCH1 (confirmed) Basal cell nevus syndrome|Basal cell carcinoma,somatic|Holoprosencephaly-7];	RCV000034575.1 [benign]; RCV000078463.5 [benign]; 	CM056376 [CLASS=DP MUT=REF PHEN="Skin cancer association with" GENE=PTCH1]; 	COSM1638395, COSM1638394, COSM1638396, COSM1638397	21787		0.099	0.4653	0.4356	198	688				
chr9	98232224	98232224	A	-	het		QUAL=705;DP=57;AF=0.53;MQM=60	PTCH1,LOC100507346	splice_region&intron,non_coding_exon	PTCH1:NM_000264.3:splice_region&intron:LOW:exon12/23:c.1729-11delT:,PTCH1:NM_001083607.1:splice_region&intron:LOW:exon12/23:c.1276-11delT:,PTCH1:NM_001083606.1:splice_region&intron:LOW:exon12/23:c.1276-11delT:,PTCH1:NM_001083604.1:splice_region&intron:LOW:exon12/23:c.1276-11delT:,PTCH1:NM_001083605.1:splice_region&intron:LOW:exon12/23:c.1276-11delT:,PTCH1:NM_001083602.1:splice_region&intron:LOW:exon12/23:c.1531-11delT:,PTCH1:NM_001083603.1:splice_region&intron:LOW:exon12/23:c.1726-11delT:,LOC100507346:NR_038982.1:non_coding_exon:MODIFIER:exon4/4:n.1887delA:			0	0.0014	0.0014	0.0018						601309 [PTCH1 (confirmed) Basal cell nevus syndrome|Basal cell carcinoma,somatic|Holoprosencephaly-7];						0	0	1	0	3				
chr10	43613843	43613843	G	T	hom		QUAL=37435;DP=1133;AF=1.00;MQM=60	RET	synonymous	RET:NM_020975.4:synonymous:LOW:exon13/20:c.2307G>T:p.Leu769Leu,RET:NM_020630.4:synonymous:LOW:exon13/19:c.2307G>T:p.Leu769Leu		rs1800861	0.7125	0.742	0.742	0.7653						164761 [RET (confirmed) Multiple endocrine neoplasia IIA|Medullary thyroid carcinoma|Multiple endocrine neoplasia IIB|Central hypoventilation syndrome,congenital|Pheochromocytoma|Renal agenesis|Hirschsprung disease,susceptibility to,1];	RCV000021844.1 [benign]; RCV000127779.1 [benign]; RCV000154625.1,RCV000153835.3 [benign,benign]; 	CM014825 [CLASS=DP MUT=REF PHEN="Hirschsprung disease association with" GENE=RET]; 		22534	351550	0.5446	0.4158	0.0396	934	602				
chr10	104264107	104264107	C	T	hom		QUAL=9683;DP=384;AF=1.00;MQM=60	SUFU,ACTR1A	splice_region&intron,upstream_gene	SUFU:NM_016169.3:splice_region&intron:LOW:exon1/11:c.182+16C>T:,SUFU:NM_001178133.1:splice_region&intron:LOW:exon1/10:c.182+16C>T:,ACTR1A:NM_005736.3:upstream_gene:MODIFIER::c.-109G>A:		rs2274351	0.3962	0.477	0.477	0.56						607035 [SUFU (confirmed) Medulloblastoma,desmoplastic|Meningioma,familial,susceptibility to|Basal cell nevus syndrome];						0.2772	0.5347	0.1881	116	190				
chr10	104389932	104389932	T	G	hom		QUAL=59124;DP=1845;AF=1.00;MQM=60	SUFU	3'UTR	SUFU:NM_016169.3:3'UTR:MODIFIER:exon12/12:c.*20T>G:		rs4917980	0.9974	0.999	0.999	1										28824		1	0	0	477	0				
chr11	64572018	64572018	T	C	hom		QUAL=8053;DP=246;AF=1.00;MQM=60	MEN1,MAP4K2	missense,upstream_gene	MEN1:NM_000244.3:missense:MODERATE:exon10/10:c.1636A>G:p.Thr546Ala,MEN1:NM_130800.2:missense:MODERATE:exon10/10:c.1636A>G:p.Thr546Ala,MEN1:NM_130801.2:missense:MODERATE:exon10/10:c.1636A>G:p.Thr546Ala,MEN1:NM_130799.2:missense:MODERATE:exon10/10:c.1621A>G:p.Thr541Ala,MEN1:NM_130802.2:missense:MODERATE:exon10/10:c.1636A>G:p.Thr546Ala,MEN1:NM_130803.2:missense:MODERATE:exon10/10:c.1636A>G:p.Thr546Ala,MEN1:NM_130804.2:missense:MODERATE:exon11/11:c.1636A>G:p.Thr546Ala,MAP4K2:NM_004579.3:upstream_gene:MODIFIER::c.-93A>G:		rs2959656	0.8345	0.938	0.938	0.9959	0.1310	T	T,T,T,T,T,T,T,T,T,T	B,B,B	B,B,B	613733 [MEN1 (confirmed) Multiple endocrine neoplasia 1|Carcinoid tumor of lung|Parathyroid adenoma,somatic|Lipoma,somatic|Angiofibroma,somatic|Adrenal adenoma,somatic];	RCV000034785.3 [benign]; RCV000082334.5,RCV000121334.3 [benign,benign]; 	CM085535 [CLASS=DFP MUT=REF PHEN="Impaired sensitisation to apoptosis" GENE=MEN1]; 	COSM255213			1	0	0	1438	20				
chr11	64572557	64572557	A	G	hom		QUAL=6507;DP=200;AF=1.00;MQM=60	MEN1,MAP4K2	synonymous,upstream_gene	MEN1:NM_000244.3:synonymous:LOW:exon9/10:c.1314T>C:p.His438His,MEN1:NM_130800.2:synonymous:LOW:exon9/10:c.1314T>C:p.His438His,MEN1:NM_130801.2:synonymous:LOW:exon9/10:c.1314T>C:p.His438His,MEN1:NM_130799.2:synonymous:LOW:exon9/10:c.1299T>C:p.His433His,MEN1:NM_130802.2:synonymous:LOW:exon9/10:c.1314T>C:p.His438His,MEN1:NM_130803.2:synonymous:LOW:exon9/10:c.1314T>C:p.His438His,MEN1:NM_130804.2:synonymous:LOW:exon10/11:c.1314T>C:p.His438His,MAP4K2:NM_004579.3:upstream_gene:MODIFIER::c.-93T>C:		rs540012	0.976	0.993	0.993	0.9997						613733 [MEN1 (confirmed) Multiple endocrine neoplasia 1|Carcinoid tumor of lung|Parathyroid adenoma,somatic|Lipoma,somatic|Angiofibroma,somatic|Adrenal adenoma,somatic];	RCV000153486.2 [benign]; 					1	0	0	1462	3				
chr11	108183167	108183167	A	G	hom		QUAL=14153;DP=443;AF=1.00;MQM=60	ATM	missense	ATM:NM_000051.3:missense:MODERATE:exon40/63:c.5948A>G:p.Asn1983Ser		rs659243	1	1	1	0	-1.0580	T	T,T	B,B	B,B	607585 [ATM (confirmed) Ataxia-telangiectasia|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to|Lymphoma,mantle cell|T-cell prolymphocytic leukemia,somatic];	RCV000128947.1,RCV000120149.2 [benign,benign]; 			1594	351497	1	0	0	2669	0				
chr11	125525195	125525195	A	G	hom		QUAL=1963;DP=59;AF=1.00;MQM=60	CHEK1	missense,non_coding_exon	CHEK1:NM_001114121.2:missense:MODERATE:exon13/14:c.1411A>G:p.Ile471Val,CHEK1:NM_001114122.2:missense:MODERATE:exon13/13:c.1411A>G:p.Ile471Val,CHEK1:NM_001244846.1:missense:MODERATE:exon12/12:c.1309A>G:p.Ile437Val,CHEK1:NM_001274.5:missense:MODERATE:exon13/13:c.1411A>G:p.Ile471Val,CHEK1:NR_045204.1:non_coding_exon:MODIFIER:exon12/12:n.2084A>G:,CHEK1:NR_045205.1:non_coding_exon:MODIFIER:exon13/13:n.1845A>G:		rs506504	0.9858	0.973	0.973	0.9637	1.1780	T	T,T,T,T,T,T,T	B,B,B	B,B,B					4189		0.9406	0.0594	0	1088	76				
chr15	43707808	43707808	A	T	het		QUAL=1980;DP=130;AF=0.47;MQM=60	TP53BP1,RNU6-28P	synonymous,intron	TP53BP1:NM_001141980.1:synonymous:LOW:exon23/28:c.5073T>A:p.Ser1691Ser,TP53BP1:NM_001141979.1:synonymous:LOW:exon23/28:c.5073T>A:p.Ser1691Ser,TP53BP1:NM_005657.2:synonymous:LOW:exon23/28:c.5058T>A:p.Ser1686Ser,RNU6-28P:NR_046489.1.2:intron:MODIFIER:exon4/4:n.34+24389A>T:		rs2230451	0.1286	0.163	0.163	0.19									COSM3754329			0.0198	0.297	0.6832	73	430				
chr15	43724646	43724646	T	G	hom		QUAL=19907;DP=624;AF=1.00;MQM=60	TP53BP1,RNU6-28P	missense,intron	TP53BP1:NM_001141980.1:missense:MODERATE:exon17/28:c.3421A>C:p.Lys1141Gln,TP53BP1:NM_001141979.1:missense:MODERATE:exon17/28:c.3421A>C:p.Lys1141Gln,TP53BP1:NM_005657.2:missense:MODERATE:exon17/28:c.3406A>C:p.Lys1136Gln,RNU6-28P:NR_046489.1.2:intron:MODIFIER:exon4/4:n.34+41227T>G:		rs2602141	0.5264	0.375	0.375	0.3036	3.2610	T	T,T,T,T	B,B,B,B	B,B,B,B			CM067476 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=TP53BP1]; 	COSM3754330			0.0792	0.4059	0.5149	168	557				
chr15	43748304	43748304	A	G	hom		QUAL=30130;DP=949;AF=1.00;MQM=60	TP53BP1,RNU6-28P	synonymous,intron	TP53BP1:NM_001141980.1:synonymous:LOW:exon12/28:c.2502T>C:p.Asp834Asp,TP53BP1:NM_001141979.1:synonymous:LOW:exon12/28:c.2502T>C:p.Asp834Asp,TP53BP1:NM_005657.2:synonymous:LOW:exon12/28:c.2487T>C:p.Asp829Asp,RNU6-28P:NR_046489.1.2:intron:MODIFIER:exon4/4:n.34+64885A>G:		rs690367	0.5262	0.374	0.374	0.3032									COSM3754331			0.0792	0.4059	0.5149	169	554				
chr15	43762196	43762196	C	T	het	pred_pathogenic_1	QUAL=3865;DP=203;AF=0.59;MQM=60	TP53BP1,RNU6-28P	missense,intron	TP53BP1:NM_001141980.1:missense:MODERATE:exon11/28:c.1249G>A:p.Gly417Ser,TP53BP1:NM_001141979.1:missense:MODERATE:exon11/28:c.1249G>A:p.Gly417Ser,TP53BP1:NM_005657.2:missense:MODERATE:exon11/28:c.1234G>A:p.Gly412Ser,RNU6-28P:NR_046489.1.2:intron:MODIFIER:exon4/4:n.34+78777C>T:		rs689647	0.3824	0.206	0.206	0.113	1.1390	T	D,D,D,D,T	B,B,B,B	B,B,B,B			CM107902 [CLASS=DP MUT=ALT PHEN="Basal cell carcinoma reduced risk association with" GENE=TP53BP1]; 	COSM3754332			0.0198	0.1881	0.7921	26	263				
chr15	43767774	43767774	G	C	hom		QUAL=3608;DP=116;AF=1.00;MQM=60	TP53BP1,RNU6-28P	missense,intron	TP53BP1:NM_001141980.1:missense:MODERATE:exon9/28:c.1074C>G:p.Asp358Glu,TP53BP1:NM_001141979.1:missense:MODERATE:exon9/28:c.1074C>G:p.Asp358Glu,TP53BP1:NM_005657.2:missense:MODERATE:exon9/28:c.1059C>G:p.Asp353Glu,RNU6-28P:NR_046489.1.2:intron:MODIFIER:exon4/4:n.34+84355G>C:		rs560191	0.5258	0.374	0.374	0.3029	0.2260	T	T,T,T,T,T	B,B,B,B	B,B,B,B			CM067475 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=TP53BP1]; 	COSM3744615			0.0792	0.4059	0.5149	169	554				
chr16	3639139	3639139	A	G	het		QUAL=1640;DP=100;AF=0.53;MQM=60	SLX4	synonymous	SLX4:NM_032444.2:synonymous:LOW:exon12/15:c.4500T>C:p.Asn1500Asn		rs3810812	0.7396	0.611	0.611	0.5077						613278 [SLX4 (provisional) Fanconi anemia,complementation group P];				27372		0.2475	0.5545	0.198	393	685				
chr16	3639230	3639230	G	A	het	anno_pathogenic_hgmd	QUAL=1724;DP=109;AF=0.49;MQM=60	SLX4	missense	SLX4:NM_032444.2:missense:MODERATE:exon12/15:c.4409C>T:p.Pro1470Leu		rs72778139	0.0002	0.0001	0.0001	0.0002	0.3390	T	T	P	B	613278 [SLX4 (provisional) Fanconi anemia,complementation group P];		CM136925 [CLASS=DM MUT=ALT PHEN="Breast and/or ovarian cancer" GENE=SLX4]; 		27372		0	0	1	0	1				
chr16	68771372	68771372	C	T	hom		QUAL=3991;DP=125;AF=1.00;MQM=60	CDH1	splice_region&intron	CDH1:NM_004360.3:splice_region&intron:LOW:exon1/15:c.48+6C>T:		rs3743674	0.7634	0.731	0.731	0.9074						192090 [CDH1 (confirmed) Endometrial carcinoma,somatic|Ovarian carcinoma,somatic|Breast cancer,lobular|Gastric cancer,familial diffuse,with or without cleft lip and/or palate|Prostate cancer,susceptibility to];	RCV000132163.2 [benign]; RCV000173339.1 [benign]; 			3802		0.7624	0.2277	0.0099	1155	287				
chr16	89838078	89838078	A	G	het		QUAL=15879;DP=1034;AF=0.48;MQM=60	FANCA	splice_region&intron	FANCA:NM_000135.2:splice_region&intron:LOW:exon23/42:c.2151+8T>C:,FANCA:NM_001286167.1:splice_region&intron:LOW:exon23/42:c.2151+8T>C:		rs1800340	0.5599	0.431	0.431	0.3077						607139 [FANCA (confirmed) Fanconi anemia,complementation group A];				8006		0.0792	0.396	0.5248	161	661				
chr16	89849480	89849480	C	T	hom		QUAL=6699;DP=199;AF=1.00;MQM=60	FANCA	missense	FANCA:NM_000135.2:missense:MODERATE:exon16/43:c.1501G>A:p.Gly501Ser,FANCA:NM_001286167.1:missense:MODERATE:exon16/43:c.1501G>A:p.Gly501Ser		rs2239359	0.624	0.499	0.499	0.381	-0.0380	T	T	B,B	B,B	607139 [FANCA (confirmed) Fanconi anemia,complementation group A];	RCV000120917.1 [not provided]; 	CM137880 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=FANCA]; 		8006		0.1386	0.5248	0.3366	271	763				
chr16	89866043	89866043	T	C	het		QUAL=11520;DP=724;AF=0.50;MQM=60	FANCA	missense	FANCA:NM_000135.2:missense:MODERATE:exon9/43:c.796A>G:p.Thr266Ala,FANCA:NM_001286167.1:missense:MODERATE:exon9/43:c.796A>G:p.Thr266Ala,FANCA:NM_001018112.1:missense:MODERATE:exon9/11:c.796A>G:p.Thr266Ala		rs7190823	0.6905	0.517	0.517	0.3937	0.4020	T	T,T,T,T	B,B,B,B,B,B	B,B,B,B,B,B	607139 [FANCA (confirmed) Fanconi anemia,complementation group A];	RCV000120967.1 [not provided]; 	CM137879 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=FANCA]; 		8006		0.1485	0.4059	0.4455	256	731				
chr17	29553485	29553485	G	A	hom		QUAL=2516;DP=83;AF=1.00;MQM=60	NF1	synonymous,downstream_gene	NF1:NM_001042492.2:synonymous:LOW:exon18/58:c.2034G>A:p.Pro678Pro,NF1:NM_000267.3:synonymous:LOW:exon18/57:c.2034G>A:p.Pro678Pro,NF1:NM_001128147.2:downstream_gene:MODIFIER::c.*2165G>A:		rs2285892	0.4968	0.382	0.382	0.2891						613113 [NF1 (confirmed) Neurofibromatosis,type 1|Leukemia,juvenile myelomonocytic|Neurofibromatosis,familial spinal|Neurofibromatosis-Noonan syndrome|Watson syndrome];	RCV000162648.1 [benign]; 			17898		0.1188	0.396	0.4851	138	634				
chr17	59760996	59760996	A	G	hom		QUAL=7602;DP=305;AF=1.00;MQM=60	BRIP1	synonymous	BRIP1:NM_032043.2:synonymous:LOW:exon20/20:c.3411T>C:p.Tyr1137Tyr		rs4986763	0.6208	0.594	0.594	0.5869						605882 [BRIP1 (confirmed) Breast cancer,early-onset|Fanconi anemia,complementation group J];	RCV000162378.1 [benign]; 			2217		0.2277	0.5149	0.2574	564	780				
chr17	59763465	59763465	T	C	hom		QUAL=3657;DP=113;AF=1.00;MQM=60	BRIP1	synonymous	BRIP1:NM_032043.2:synonymous:LOW:exon19/20:c.2637A>G:p.Glu879Glu		rs4986765	0.8151	0.719	0.719	0.6555						605882 [BRIP1 (confirmed) Breast cancer,early-onset|Fanconi anemia,complementation group J];	RCV000162379.1 [benign]; 		COSM437064, COSM1479821	2217		0.3465	0.5248	0.1287	754	705				
chr19	17389648	17389648	C	T	het		QUAL=1535;DP=106;AF=0.47;MQM=60	BABAM1,ANKLE1	splice_region&intron,upstream_gene	BABAM1:NM_001033549.2:splice_region&intron:LOW:exon8/8:c.787-6C>T:,BABAM1:NM_001288756.1:splice_region&intron:LOW:exon8/8:c.787-6C>T:,BABAM1:NM_001288757.1:splice_region&intron:LOW:exon5/5:c.562-6C>T:,BABAM1:NM_014173.3:splice_region&intron:LOW:exon8/8:c.787-6C>T:,ANKLE1:NM_152363.5:upstream_gene:MODIFIER::c.-115C>T:,ANKLE1:NM_001278443.1:upstream_gene:MODIFIER::c.-115C>T:,ANKLE1:NM_001278444.1:upstream_gene:MODIFIER::c.-115C>T:,ANKLE1:NM_001278445.1:upstream_gene:MODIFIER::c.-206C>T:,ANKLE1:NR_103530.1:upstream_gene:MODIFIER::n.-1C>T:		rs10406920	0.1118	0.148	0.148	0.1799												0.0297	0.2772	0.6931	33	301				
chr19	17389704	17389704	G	A	het		QUAL=7841;DP=526;AF=0.47;MQM=60	BABAM1,ANKLE1	synonymous,upstream_gene	BABAM1:NM_001033549.2:synonymous:LOW:exon9/9:c.837G>A:p.Lys279Lys,BABAM1:NM_001288756.1:synonymous:LOW:exon9/9:c.837G>A:p.Lys279Lys,BABAM1:NM_001288757.1:synonymous:LOW:exon6/6:c.612G>A:p.Lys204Lys,BABAM1:NM_014173.3:synonymous:LOW:exon9/9:c.837G>A:p.Lys279Lys,ANKLE1:NM_152363.5:upstream_gene:MODIFIER::c.-115G>A:,ANKLE1:NM_001278443.1:upstream_gene:MODIFIER::c.-115G>A:,ANKLE1:NM_001278444.1:upstream_gene:MODIFIER::c.-115G>A:,ANKLE1:NM_001278445.1:upstream_gene:MODIFIER::c.-206G>A:,ANKLE1:NR_103530.1:upstream_gene:MODIFIER::n.-1G>A:		rs8170	0.1124	0.152	0.152	0.1811								CM1010189 [CLASS=DP MUT=ALT PHEN="Ovarian cancer susceptibility to" GENE=BABAM1]; 	COSM438891, COSM438892			0.0297	0.2772	0.6931	33	302				
